Navigation Links
TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
Date:8/8/2008

- Dr. Neil Kurtz Resigns as President and Chief Executive Officer; Evelyn

Graham Appointed Acting Chief Executive Officer -

LA JOLLA, Calif., Aug. 8 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that Neil Kurtz, M.D., is resigning as President, Chief Executive Officer and a director of the company effective as of August 31, 2008. Dr. Kurtz is leaving TorreyPines to assume the role of President and Chief Executive Officer with a major healthcare services company. TorreyPines also named his replacement with the appointment of Evelyn Graham as acting Chief Executive Officer. Ms. Graham has been the company's Chief Operating Officer since 2006.

"We thank Neil for his leadership and many contributions to TorreyPines during his tenure as CEO," said Peter Davis, Ph.D., Chairman of the Board of Directors of TorreyPines.

Dr. Davis continued, "We are proud to announce the appointment of Ev as acting CEO. Her extensive drug development experience and detailed understanding of the company make her the perfect fit to lead TorreyPines as we continue to advance our programs through significant regulatory and clinical milestones."

"I look forward to continuing to work with our current management team in this new role to realize the full potential of our promising product candidates," said Ms. Graham. "We are currently preparing for our end of Phase II meeting with the FDA on September 29th during which we will discuss our proposed Phase III migraine program for tezampanel. In addition, we are continuing to advance NGX426, the oral version of tezampanel, having initiated a Phase I clinical trial to evaluate its analgesic effect. We anticipate announcing results from this Pha
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
2. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
3. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
4. TorreyPines Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference
5. TorreyPines Therapeutics to Present at the JMP Securities Healthcare Focus Conference
6. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
7. Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
8. Nektar Therapeutics Announces Second Quarter 2008 Results
9. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
10. InteKrin Therapeutics Announces $20 Million Series C Financing
11. Transition Therapeutics Announces No Material Change

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...e, bacteria are abundant, diverse and constant, bu...iversity of California, San Diego School of Medici...e skin surface trigger a pathway that prevents exc... are actually good for us," said Richard L. Gallo,...ief of UCSD,s Division of Dermatology and the Derm...
(Date:11/22/2009)...nated cells to attack recipient,s tissue, study fi...s) -- Researchers are reporting that a genetic var...omeone who,s had a bone-marrow transplant will dev...se. , The immune system-related complication o...iation and the donor does not. , When that,s t...
(Date:11/22/2009)... HealthSmart, an innovative healthcare benefit ...cessfully completed a recapitalization with Silver... lenders. Silver Point Capital, L.P. is a private... This recapitalization allows the Company to conti.... , , (PRWEB) November 2...
(Date:11/22/2009)... Man & Machine post You Tube video demonstr...ion , Landover, MD (PRWEB...erested in learning what a really rugged waterproo...Really Cool Keyboard vs Washable Competitors Keybo...trates how the premium, Really Cool Keyboard from ...
(Date:11/21/2009)..., Nov. 21 Tonight, in a...o Senator Reid,s version of the government takeove...items included in this bill; like the public optio...ment funding for elective abortion, which is the m...y the bill provides subsidies for private plans th...
Breaking Medicine News(10 mins):Health News:Surface bacteria maintain skin's healthy balance 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2
...for insulation, anyone? Eben Bayer of Vermont and ...t, almost . The two have together created and...c, fire-retardant board made of water, flour, oyst...iendly products. Bringing the insulation to m...
...For hundreds of years, Tibetan monks and other rel...d and improve concentration. This week, a new stud... affects the brain. Using a scanner that r... paying attention and making decisions. ...
...rsonalized program delivered by mail is more effec...s struggle to become more physically active, simpl...n play a crucial role in getting people off to a g...ly more effective long-term than feedback delivere...
...rs have reported that breast masses shown on ultra... safely managed with imaging follow-up rather than...ound follow-up can spare women from unnecessary, i...ety (ACS) estimates that 212,920 women will be dia...
...ut six years ago, methamphetamine use was seen mos... methamphetamine abuse has expanded rapidly throug...ethnic groups. In recent years, the spread of meth...th (NSDUH), an estimated 10.4 million Americans ag...
...rug Trafficking is a global problem. It has certai...lobal nuisance, the world would be best without. ...y spurred this nefarious trade, giving rise to pow... of these categories - amphetamine-type stimulants...
Other Medicine News:Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 2Health News:US Whizkids Create Eco-friendly Building Material from Mushroom 3Health News:Meditation Increases Attention - A Brain Scan Report 2Health News:Meditation Increases Attention - A Brain Scan Report 3Health News:Meditation Increases Attention - A Brain Scan Report 4Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3Health News:Ultrasound Better Than Biopsy for Breast Examination 2Health News:Chronic Metamphetamine Abuse is Related to Cardiovascular Disease 2Health News:This 'Grass' is Not Green - Say, 'No Thanks, I Am Fine Without Drugs' 2Health News:This 'Grass' is Not Green - Say, 'No Thanks, I Am Fine Without Drugs' 3
(Date:11/20/2009)...ORK, Nov. 20 Reportlinker.com anno...le in its catalogue. ,, Global Self Monitoring...to Drive Growth ,, http://www.reportlinker.c...arket-(SMBG )-Increasing-Adoption-to-Drive-Growth....tm_campaign=prnewswire ,, Description ,, ...
(Date:11/20/2009)...ORK, Nov. 20 Reportlinker.com anno...le in its catalogue. ,, Global Markets for Ass...w.reportlinker.com/p0164742/Global-Markets-for-Ass...newswire&utm_medium=pr&utm_campaign=prnews...ion covers the U.S., 15 Countries in Europe and Ja...
(Date:11/20/2009)..., Nov. 20 Cyberonics, In..., President and Chief Executive Officer, and Greg ...he 21st Annual Piper Jaffray Health Care Conferenc...:00 PM EST. The conference session and webcast wi...ented. Piper Jaffray will host a webcast of the p...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 1Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 2Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 3Atomic Tattoos Announces 26quot 3BTats for Tatas 26quot 3B October Fundraising Event to Benefit Local Breast Cancer Research 59615 1Atomic Tattoos Announces 26quot 3BTats for Tatas 26quot 3B October Fundraising Event to Benefit Local Breast Cancer Research 59615 2Super sticky barnacle glue cures like blood clots 10391 1Super sticky barnacle glue cures like blood clots 10391 2Super sticky barnacle glue cures like blood clots 10391 3
...rollment in May 2009; Reinforces Lilly,s commitmen...rch , , INDIANAPOLIS, May 21 Eli Lilly and Comp...nrolling patients this month in two separate but i...i), previously referred to as LY2062430, an anti-a... as a potential treatment to delay the progression...
...mulation & eFlow Technology Delivery , , MUNI...researchers presented positive data from an ongoin... Society (ATS) International Conference that compa...disodium cromoglycate (DSCG) solution, to inhaled ...sthma. Results showed decreases in mean asthma sy...
Other Medicine Technology:Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 2Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 3Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 4Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 5PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 2PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 3PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 4PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS 5
...nnovations have become the accepted standard for,...Total Hip System was the first femoral stem to eff...r biological fixation in total hip arthroplasty. ...performance, the AML Femoral Stem continues to exc...
Taperloc Femeral Stem
Inteq® TFCC Small Joint Suturing System
Basic Small Joint Set
Medicine Products: